Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-09-05-Speech-3-428"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010905.15.3-428"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, the safety and quality of blood products have never been so important. Every week we hear across the EU story after story about this issue. I believe that every Member of the House wants to be reassured with the knowledge that there is a level of safety and quality of blood and blood products throughout the transfusion process in Member States.
For our citizens it means that in the unfortunate situation where, for instance, you have had an accident on holiday and you require a blood transfusion, you can guarantee the quality and safety being the same, whether it is on a Greek island or on a Scottish island. As we all know, the main area of difference between Members has been on the issue of remunerated and non-remunerated blood products. I believe that the preferred option should be that blood is given voluntarily. As the European Blood Alliance outline, voluntary and non-remunerated donations of blood and blood components are considered to be a gift from healthy citizens to those in need. But more importantly, the EU Charter of Fundamental Rights prohibits the making of the human body and its parts a source of financial gain.
We as a parliament, and within the institutions, have consistently advocated voluntary, non-remunerated donations. Evidence shows that the prevalence of viruses and diseases which may be transmitted through blood is higher in those donors who are remunerated than those who donate without receiving payment.
There is, however, one issue which I would like to highlight. That is Amendment No 43. In Scotland and the UK we have a specific issue with CJD. Many haemophiliacs and those with immune disorders depend on blood products from the US, the reason being that in Scotland and the UK we no longer use plasma from UK donors to make blood products because of CJD and rely instead on imports of plasma from the US.
The oral amendment advocated by Mrs Korhola to Amendment No 43 is greatly welcomed. I hope Members will support it tomorrow.
In conclusion, the safety, quality and standard of blood and blood products is an important issue which we have to get right. Perhaps in the second reading the rapporteur could organise outside this Chamber an opportunity for Members to donate blood. After all, as Members, we should lead by example. Giving blood is a positive act of citizenship."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples